Presentation + Paper
5 March 2021 MHV-1 in vivo viral load reduction via antibody-conjugated photodynamic inactivation
Jace A. Willis, Vsevolod Cheburkanov, Giulia Kassab, Vanderlei S. Bagnato, Vladislav V. Yakovlev
Author Affiliations +
Abstract
Photodynamic inactivation (PDI) has been widely applied to localized infections, both internal and external. However, there is a notable knowledge gap when it comes to applying PDI to an entire organ system or even systemically throughout an organism. To study these treatment methods, an in vivo murine model of MHV-1 is planned. As a respiratory coronavirus, the model provides a suitable system for study, in addition to potential determination of systemic results. Specifically applied, MHV-1 has many key characteristics, such as symptoms and viral protein structures, that are in common or similar to other coronaviruses. Thus, this theorized model simultaneously addresses a key knowledge gap and provides useful insights into potential treatments for COVID-19 and similar disease-causing viruses. The risk of emergent viral threats and the necessity for rapidly developed, adaptable, affordable treatment methods are both now vividly evident.
Conference Presentation
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jace A. Willis, Vsevolod Cheburkanov, Giulia Kassab, Vanderlei S. Bagnato, and Vladislav V. Yakovlev "MHV-1 in vivo viral load reduction via antibody-conjugated photodynamic inactivation", Proc. SPIE 11626, Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2021, 116260C (5 March 2021); https://doi.org/10.1117/12.2577893
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
In vivo imaging

Near infrared

Tissues

In vitro testing

Indocyanine green

Organisms

Proteins

Back to Top